GHELARDINI, CARLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 49.208
NA - Nord America 48.275
AS - Asia 19.771
SA - Sud America 3.047
Continente sconosciuto - Info sul continente non disponibili 892
AF - Africa 589
OC - Oceania 353
Totale 122.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 47.428
PL - Polonia 24.755
RU - Federazione Russa 8.824
IT - Italia 6.287
SG - Singapore 5.347
CN - Cina 4.414
HK - Hong Kong 3.193
BR - Brasile 2.504
VN - Vietnam 2.396
IE - Irlanda 2.257
SE - Svezia 1.771
KR - Corea 1.577
DE - Germania 1.092
FI - Finlandia 1.066
FR - Francia 923
UA - Ucraina 756
GB - Regno Unito 743
IN - India 665
CA - Canada 527
ID - Indonesia 400
BD - Bangladesh 370
AU - Australia 343
JP - Giappone 276
JO - Giordania 240
TR - Turchia 230
AR - Argentina 210
NL - Olanda 182
CI - Costa d'Avorio 142
MX - Messico 141
IQ - Iraq 137
ES - Italia 123
ZA - Sudafrica 102
CH - Svizzera 97
EC - Ecuador 85
PK - Pakistan 83
BE - Belgio 81
NG - Nigeria 59
MA - Marocco 58
CO - Colombia 56
SC - Seychelles 50
SA - Arabia Saudita 47
VE - Venezuela 46
EG - Egitto 45
PY - Paraguay 44
PT - Portogallo 43
UZ - Uzbekistan 39
PE - Perù 38
CL - Cile 35
AE - Emirati Arabi Uniti 34
JM - Giamaica 34
PH - Filippine 32
CR - Costa Rica 30
TN - Tunisia 29
AT - Austria 28
AZ - Azerbaigian 28
IL - Israele 28
RO - Romania 27
TH - Thailandia 27
IR - Iran 26
LT - Lituania 26
KE - Kenya 25
NP - Nepal 25
TW - Taiwan 21
LB - Libano 20
DZ - Algeria 18
AL - Albania 17
MY - Malesia 17
CZ - Repubblica Ceca 16
HN - Honduras 15
KZ - Kazakistan 15
BG - Bulgaria 14
PR - Porto Rico 14
TT - Trinidad e Tobago 14
UY - Uruguay 14
ET - Etiopia 13
GT - Guatemala 13
SN - Senegal 13
BJ - Benin 12
BO - Bolivia 12
OM - Oman 12
DO - Repubblica Dominicana 11
GR - Grecia 11
BH - Bahrain 10
KG - Kirghizistan 10
NZ - Nuova Zelanda 10
SV - El Salvador 10
AM - Armenia 8
BB - Barbados 8
HR - Croazia 8
LV - Lettonia 8
PS - Palestinian Territory 8
DK - Danimarca 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
AO - Angola 6
EU - Europa 6
KW - Kuwait 6
GE - Georgia 5
LA - Repubblica Popolare Democratica del Laos 5
NO - Norvegia 5
Totale 121.152
Salva come PNG Salva come JPEG
Città #
Warsaw 24.731
Santa Clara 8.575
Ashburn 6.032
Fairfield 4.142
Singapore 3.801
Hong Kong 2.696
Dublin 2.243
Woodbridge 1.954
Chandler 1.952
Seattle 1.741
Cambridge 1.655
Houston 1.512
San Jose 1.506
Seoul 1.443
Wilmington 1.430
Milan 1.207
Jacksonville 1.088
Beijing 1.041
Council Bluffs 863
Altamura 739
Ann Arbor 737
Hefei 705
Lawrence 692
The Dalles 662
Los Angeles 654
Princeton 624
Ho Chi Minh City 622
Florence 621
Buffalo 557
Rome 546
Lauterbourg 504
Helsinki 489
Dong Ket 445
Hanoi 440
Dallas 409
Mumbai 395
Boston 377
Moscow 362
Boardman 355
New York 332
Jakarta 311
Medford 310
Melbourne 295
San Diego 293
Munich 258
Paris 247
Phoenix 242
Tokyo 241
Shanghai 229
São Paulo 204
Kent 154
Clifton 148
Abidjan 142
Falls Church 141
London 137
Naples 132
Turin 129
Izmir 121
Orem 119
Frankfurt am Main 112
Figino 110
Turku 108
Chicago 107
Bologna 104
Norwalk 99
Redondo Beach 99
Toronto 99
Philadelphia 97
Montreal 93
Guangzhou 88
Da Nang 84
Tianjin 84
Hillsboro 80
Brooklyn 78
Miano 75
Bern 74
Seongnam 73
Brussels 71
Rio de Janeiro 69
Palermo 68
Haiphong 67
Verona 64
Washington 64
Amsterdam 62
San Francisco 62
Springfield 59
Chennai 58
Baghdad 56
Bari 55
Lappeenranta 53
Abuja 50
Denver 49
Andover 47
Barcelona 47
Belo Horizonte 46
West Jordan 46
Genoa 44
Atlanta 43
Curitiba 42
Johannesburg 42
Totale 87.660
Salva come PNG Salva come JPEG
Nome #
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer 683
M1 receptor activation is a requirement for arecoline analgesia. 628
LOCAL ANAESTHETIC AVTIVITY OF ESSENTIAL OIL OF LAVANDULA ANGUSTIFOLIA 544
Antinociceptive property of the nicotinic agonist AG4 in rodents 528
Acetyl-l-Carnitine in the Management of Pain During Methadone Withdrawal Syndrome. 487
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 443
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 425
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 413
The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and rats 412
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 401
AMITRIPTYLINE AND CLOMIPRAMINE ACTIVATE GI-PROTEIN SIGNALING PATHWAY IN THE INDUCTION OF ANALGESIA 398
HYPOFUNCTIONALITY OF GI PROTEINS AS AETIOPHATOGENETIC MECHANISM FOR MIGRAINE AND CLUSTER HEADACHE 398
Ryanodine receptors are involved in muscarinic antinociception in mice. 397
A Prolonged Protein Kinase C-Mediated, Opioid-Related Antinociceptive Effect of St John's Wort in Mice 392
Acute effect of Capparis spinosa root extracts on rat articular pain 388
3-ALFA-TROPANYL 2-(4-Cl-PHENOXY)BUTIRATE (SM21): A REVIEW OF THE PHARMACOLOGICAL PROFILE OF A NOVEL ENHANCER OF CHOLINERGIC TRANSMISSION. 378
A novel manganese complex effective as superoxide anion scavenger and therapeutic agent against cell and tissue oxidative injury. 377
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling. 376
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy 372
4-methyl benzylamine stimulates food consumption and counteracts the hypophagic effects of amphetamine acting on brain Shaker-like Kv1.1 channels. 368
Neurotransmitter role of endogenous morphine in CNS. 366
NO DEVELOPMENT OF TOLERANCE TO ANALGESIA BY REPEATED ADMINISTRATION OF H1 ANTAGONISTS 365
Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy? 365
A REDUCED FUNCTIONALITY OF GI PROTEINS AS A POSSIBLE CAUSE FOR FIBROMYALGIA 364
The central analgesia induced by antimigraine drugs is independent from Gi proteins: superiority of a fixed combination of indomethacin, prochlorperazine and caffeine, compared to sumatriptan, in an in vivo model. 364
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 362
Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARc Agonism as Preventive Pharmacological Approach 361
Synthesis of novel cognition enhancer with pyrazolo[5,1-c][1,2,4]benzotriazine core acting at gamma-aminobutyric acid type A (GABAA) receptor. 361
5-HT1A AGONISTS INDUCE CENTRAL CHOLINERGIC ANTINOCICEPTION 359
α7 Nicotinic Receptor Promotes the Neuroprotective Functions of Astrocytes against Oxaliplatin Neurotoxicity 356
Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation 354
Design, synthesis and binding affinity of new nicotinic ligands 352
A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. 346
Local anaesthetic activity of beta-caryophyllene. 346
Aminopyrrolic synthetic receptors for monosaccharides: A class of carbohydrate-binding agents endowed with antibiotic activity versus pathogenic yeasts 345
PIRACETAM AND ANIRACETAM ANTAGONISM OF CENTRALLY ACTIVE DRUG-INDUCED ANTINOCICEPTION 343
Bacopa monnieri as augmentation therapy in the treatment of anhedonia, preclinical and clinical evaluation 342
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 341
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 338
Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats 338
Antihyperalgesic activity of verbascoside in two models of neuropathic pain. 337
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 335
ACETYL-L-CARNITINE INDUCES MUSCARINIC ANTINOCICEPTION IN MICE AND RATS 335
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity 335
Antihyperalgesic activity of verbascoside in the chronic constriction injury of the sciatic nerve (CCI) and intra-articular injection of sodium monoiodoacetate (MIA) models of neuropatic pain 335
Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy 335
Novel ester and acid derivatives of the 1,5-diarylpyrrole scaffold as anti-inflammatory and analgesic agents. Synthesis and in vitro and in vivo biological evaluation. 333
Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. 332
Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: Relevance of nicotinic receptors 332
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. 332
Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: An antisense study. 330
Delay of morphine tolerance by palmitoylethanolamide 330
Apoptotic Process Induced by Oxaliplatin in Rat Hippocampus Causes Memory Impairment 329
Antisense knockdown of the Shaker Kv1.1 gene family abolishes the central stimulatory effect of amphetamines in mice and rats. 328
Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. 328
BDNF and ARTEMIN are increased in drug-naïve non-depressed GAD patients: Preliminary data 327
LOCAL ANAESTHETIC ACTIVITY OF MONOTERPENES AND PHENYLPROPANES OF ESSENTIAL OILS 325
Methylamine: a new endogenous modulator of neuron firing? 325
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 325
An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown. 324
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 324
Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. 323
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 323
The pharmacological basis of opioids 323
Baclofen antinociception is prevented by ICV injection of pertussis toxin and by an aODN to the mKv1.1 potassium channel.. 322
Pro-cognitive activity induced in the rat by low doses of R-(+)-hyoscyamine. 321
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 320
EFFECT OF POTASSIUM CHANNEL MODULATORS IN MOUSE FORCED SWIMMING TEST 320
Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation 319
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 318
Improving the therapeutic efficacy of prilocaine by PLGA microparticles: Preparation, characterization and in vivo evaluation. 317
The Role of TRPA1 and TRPV1 Channels in Orofacial Pain 317
Role of intracellular calcium in acute thermal pain perception 316
THE REDUCTION OF FOOD INTAKE INDUCED IN MICE BY BENZYLAMINE AND ITS DERIVATIVES 315
Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition-enhancers 315
Acute visceral pain relief mediated by A(3)AR agonists in rats: involvement of N-type voltage-gated calcium channels 315
Effect of K+ channel modulation on mouse feeding behaviour 314
Central muscarinic antinociception induced by ET-142 and SS-20 in rodents 314
CENTRAL CHOLINERGIC CHALLENGING OF MIGRAINE BY TESTING SECOND-GENERATION ANTICHOLINESTERASE DRUG 313
IMPROVEMENT OF COGNITIVE FUNCTIONS BY THE ACETYLCHOLINE RELEASER SM21 311
Selenium and zinc: Two key players against cadmium-induced neuronal toxicity. 311
Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. 310
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 308
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 308
Prochlorperazine induces central antinociception mediated by the muscarinic system. 307
Contribution of G inhibitory protein alpha subunits in paradoxical hyperalgesia elicited by exceedingly low doses of morphine in mice. 307
PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL ACH RELEASER A-TROPANYL 2-(4-BROMOPHENYL)PROPIONATE (PG-9). 307
A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin 307
ANTIAMNESIC ACTIVITY OF THE NICOTINIC AGONIST DBO-83 IN MICE 306
Methylamine and benzylamine induced hypophagia in mice: Modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels 306
Influence of potassium channel modulators on cognitive processes in mice 305
KV1.1 CHANNEL ANTISENSE ATTENUATES LEARNING AND MODULATION OF DENTATE POLYSIALYLATED NCAM 304
Pharmacological in vivo test to evaluate the bioavailability of some St. John's wort innovative oral preparations 304
Identification of a new pyrazolo[1,5-a]quinazoline ligand highly affine to γ-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity 304
Effects of Hypericum perforatum extract on oxaliplatin-induced neurotoxicity: in vitro evaluations 304
Alpha-2 agonits induce amnesia through activation of the Gi-protein signalling pathway. 303
EFFECT OF PERTUSSIS TOXIN ON BACLOFEN-AND DIPHENHYDRAMINE- INDUCED AMNESIA 303
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(phenylthio)- and 2-(phenylamino)alkanoic Acid Esters 302
Diphenhydramine-induced amnesia is mediated by Gi-protein activation. 302
Salvianolic acid B and its liposomal formulations: anti-hyperalgesic activity in the treatment of neuropathic pain. 302
Totale 34.958
Salva come PNG Salva come JPEG
Categoria #
all - tutte 303.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 303.120
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.094 0 372 409 159 141 239 172 309 262 302 662 1.067
2022/20239.590 964 1.980 444 564 682 1.670 1.325 525 928 59 289 160
2023/20243.915 172 407 670 187 268 562 162 893 83 198 187 126
2024/202525.998 876 2.737 1.729 3.615 7.326 3.327 612 1.429 1.548 783 1.088 928
2025/202632.406 3.041 3.923 2.478 2.634 3.254 1.404 3.594 1.708 2.332 2.221 1.583 4.234
2026/20271.560 1.359 201 0 0 0 0 0 0 0 0 0 0
Totale 122.135